These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14998260)

  • 1. Heart failure: diagnosis and healthcare burden.
    Dayer M; Cowie MR
    Clin Med (Lond); 2004; 4(1):13-8. PubMed ID: 14998260
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
    Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congestive heart failure and atrial natriuretic factor: a room for endothelins?
    Tuzcu V; Savasan S
    Am J Cardiol; 1996 Jul; 78(1):128-9. PubMed ID: 8712108
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic strategy in heart failure].
    Gustafsson F; Boesgaard S; Gadsbøll N; Aldershvile J; Hildebrandt R
    Ugeskr Laeger; 2004 Jan; 166(4):253-5. PubMed ID: 14964103
    [No Abstract]   [Full Text] [Related]  

  • 5. [Natriuretic peptides BNP and NT-pro-BNP--the "new troponins" for estimation of heart failure?].
    Pfister R; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2003 May; 128(18):1007-12. PubMed ID: 12721882
    [No Abstract]   [Full Text] [Related]  

  • 6. Nesiritide in acute heart failure.
    de Moraes Barros GD; de Carvalho Leite CR
    Lancet; 2003 Sep; 362(9388):999. PubMed ID: 14511941
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomarkers in patients with acute dyspnoea: what for?
    Brunner-La Rocca HP; Sanders-van Wijk S; Knackstedt C
    Eur Heart J; 2012 Sep; 33(17):2124-6. PubMed ID: 22807467
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart disease.
    Heringlake M; Kox T; Poeling J; Klaus S; Hanke T; Franz N; Eberhardt F; Heinze H; Armbruster FP; Bahlmann L
    Eur J Med Res; 2009 Mar; 14(3):106-12. PubMed ID: 19380280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure.
    Larsen AI; Hall C; Aukrust P; Aarsland T; Faris P; Dickstein K
    Am J Cardiol; 2003 Jul; 92(1):91-4. PubMed ID: 12842259
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospects for using a blood sample in the diagnosis of heart failure.
    Struthers AD
    QJM; 1995 May; 88(5):303-6. PubMed ID: 7796082
    [No Abstract]   [Full Text] [Related]  

  • 11. New-onset heart failure: free-breathing motion-corrected late gadolinium enhancement rescues the endomyocardial fibrosis diagnosis.
    Chatha SR; Westwood M; Moon JC; Captur G
    Eur Heart J; 2019 Dec; 40(48):3951. PubMed ID: 31562499
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure.
    Dickstein K; Larsen AI; Bonarjee V; Thoresen M; Aarsland T; Hall C
    Am J Cardiol; 1995 Oct; 76(10):679-83. PubMed ID: 7572624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only.
    Struthers AD
    Heart; 2002 Feb; 87(2):97-8. PubMed ID: 11796533
    [No Abstract]   [Full Text] [Related]  

  • 14. Multifactorial regulation of plasma natriuretic peptides calls for supplementary measurements.
    Lindstedt G
    Scand Cardiovasc J; 2001 Dec; 35(6):355-8. PubMed ID: 11837513
    [No Abstract]   [Full Text] [Related]  

  • 15. Mid-regional pro-atrial natriuretic peptide for the early detection of non-acute heart failure.
    Gohar A; Rutten FH; den Ruijter H; Kelder JC; von Haehling S; Anker SD; Möckel M; Hoes AW
    Eur J Heart Fail; 2019 Oct; 21(10):1219-1227. PubMed ID: 31209992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide.
    Fischer Y; Filzmaier K; Stiegler H; Graf J; Fuhs S; Franke A; Janssens U; Gressner AM
    Clin Chem; 2001 Mar; 47(3):591-4. PubMed ID: 11238315
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter by Chung et al regarding article, "N-terminal pro B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF study".
    Chung T; Sindone A; Freedman SB
    Circulation; 2008 Jan; 117(1):e5; author reply e6. PubMed ID: 18172041
    [No Abstract]   [Full Text] [Related]  

  • 18. Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failure.
    Stanek B; Frey B; Hülsmann M; Koller-Strametz J; Hartter E; Schuller M; Ogris E; Maurer G; Pacher R
    Transplant Proc; 1997; 29(1-2):595-6. PubMed ID: 9123146
    [No Abstract]   [Full Text] [Related]  

  • 19. Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head-to-head comparison of four cardiac natriuretic peptides.
    Alehagen U; Svensson E; Dahlström U
    J Card Fail; 2007 Aug; 13(6):452-61. PubMed ID: 17675059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: effect of angiotensin II receptor antagonism.
    Klinge R; Djøseland O; Karlberg BE; Hall C
    Clin Physiol; 1997 Jul; 17(4):389-400. PubMed ID: 19361150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.